Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 30;5(6):e28952.
doi: 10.2196/28952.

A Web-Based Intervention to Increase Smokers' Intentions to Participate in a Cessation Study Offered at the Point of Lung Screening: Factorial Randomized Trial

Jordan M Neil  1   2   3 , Yuchiao Chang  2   3   4 , Brett Goshe  2   5 , Nancy Rigotti  3   4 , Irina Gonzalez  2 , Saif Hawari  2 , Lauren Ballini  6 , Jennifer S Haas  3 , Caylin Marotta  3 , Amy Wint  3 , Kim Harris  3 , Sydney Crute  3 , Efren Flores  2   7 , Elyse R Park  2   4   5
Affiliations

A Web-Based Intervention to Increase Smokers' Intentions to Participate in a Cessation Study Offered at the Point of Lung Screening: Factorial Randomized Trial

Jordan M Neil et al. JMIR Form Res. .

Abstract

Background: Screen ASSIST is a cessation trial offered to current smokers at the point of lung cancer screening. Because of the unique position of promoting a prevention behavior (smoking cessation) within the context of a detection behavior (lung cancer screening), this study employed prospect theory to design and formatively evaluate a targeted recruitment video prior to trial launch.

Objective: The aim of this study was to identify which message frames were most effective at promoting intent to participate in a smoking cessation study.

Methods: Participants were recruited from a proprietary opt-in online panel company and randomized to a 2 (benefits of quitting vs risks of continuing to smoke at the time of lung screening; BvR) × 2 (gains of participating vs losses of not participating in a cessation study; GvL) message design experiment (N=314). The primary outcome was self-assessed intent to participate in a smoking cessation study. Message effectiveness and lung cancer risk perception measures were also collected. Analysis of variance examined the main effect of the 2 message factors and a least absolute shrinkage and selection operator (LASSO) approach identified predictors of intent to participate in a multivariable model. A mediation analysis was conducted to determine the direct and indirect effects of message factors on intent to participate in a cessation study.

Results: A total of 296 participants completed the intervention. There were no significant differences in intent to participate in a smoking cessation study between message frames (P=.12 and P=.61). In the multivariable model, quit importance (P<.001), perceived message relevance (P<.001), and affective risk response (ie, worry about developing lung cancer; P<.001) were significant predictors of intent to participate. The benefits of quitting frame significantly increased affective risk response (Meanbenefits 2.60 vs Meanrisk 2.40; P=.03), which mediated the relationship between message frame and intent to participate (b=0.24; 95% CI 0.01-0.47; P=.03).

Conclusions: This study provides theoretical and practical guidance on how to design and evaluate proactive recruitment messages for a cessation trial. Based on our findings, we conclude that heavy smokers are more responsive to recruitment messages that frame the benefits of quitting as it increased affective risk response, which predicted greater intention to participate in a smoking cessation study.

Keywords: clinical trials recruitment; digital outreach; lung cancer screening; message design experiment; prospect theory; smoking cessation.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020 Jan;70(1):7–30. doi: 10.3322/caac.21590. doi: 10.3322/caac.21590. - DOI - DOI - PubMed
    1. Walser T, Cui X, Yanagawa J, Lee JM, Heinrich E, Lee G, Sharma S, Dubinett SM. Smoking and Lung Cancer: The Role of Inflammation. Proceedings of the American Thoracic Society. 2008 Dec 01;5(8):811–815. doi: 10.1513/pats.200809-100TH. - DOI - PMC - PubMed
    1. CDC Current Cigarette Smoking Among Adults in the United States. Centers for Disease Control and Prevention. [2021-06-09]. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_s....
    1. USPSTF Final Recommendation Statement: Lung Cancer: Screening | United States Preventive Services Taskforce. Published. 2013. [2021-06-09]. https://www.uspreventiveservicestaskforce.org/uspstf/document/Recommenda....
    1. Joseph AM, Rothman AJ, Almirall D, Begnaud A, Chiles C, Cinciripini PM, Fu SS, Graham AL, Lindgren BR, Melzer AC, Ostroff JS, Seaman EL, Taylor KL, Toll BA, Zeliadt SB, Vock DM. Lung Cancer Screening and Smoking Cessation Clinical Trials. SCALE (Smoking Cessation within the Context of Lung Cancer Screening) Collaboration. Am J Respir Crit Care Med. 2018 Jan 15;197(2):172–182. doi: 10.1164/rccm.201705-0909ci. - DOI - PMC - PubMed

LinkOut - more resources